Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2019 from OUS - Dept. of Gastroenterology RH (Div SIMT)

7 publications found

Bekkelund M, Sangnes DA, Gunnar Hatlebakk J, Aabakken L (2019)
Pathophysiology of idiopathic gastroparesis and implications for therapy
Scand J Gastroenterol, 1-10 (in press)
DOI 10.1080/00365521.2018.1558280, PubMed 30638082

García-Albéniz X, Hsu J, Bretthauer M, Hernán MA (2019)
Estimating the Effect of Preventive Services with Databases of Administrative Claims: Reasons to Be Concerned
Am J Epidemiol (in press)
DOI 10.1093/aje/kwz049, PubMed 30869122

Gidoni M, Snir O, Peres A, Polak P, Lindeman I, Mikocziova I, Sarna VK, Lundin KEA, Clouser C, Vigneault F, Collins AM, Sollid LM, Yaari G (2019)
Mosaic deletion patterns of the human antibody heavy chain gene locus shown by Bayesian haplotyping
Nat Commun, 10 (1), 628
DOI 10.1038/s41467-019-08489-3, PubMed 30733445

Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KE, Tveit KS, Lorentzen M, Berset IP, Fevang BT, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G et al. (2019)
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: Open-label extension of the NOR-SWITCH trial
J Intern Med (in press)
DOI 10.1111/joim.12880, PubMed 30762274

Randel KR, Botteri E, Romstad KMK, Frigstad SO, Bretthauer M, Hoff G, de Lange T, Holme Ø (2019)
Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening
Gastroenterology (in press)
DOI 10.1053/j.gastro.2019.01.040, PubMed 30689972

Refsum E, Helsingen LM, Jodal HC, Løberg M, Høstmælingen N, Kalager M (2019)
Personvern – en hinderløype
Tidsskr Nor Laegeforen, 139 (4)
DOI 10.4045/tidsskr.19.0077, PubMed 30808102

Saffioti F, Roccarina D, Vesterhus M, Hov JR, Rosenberg W, Pinzani M, Pereira SP, Boberg KM, Thorburn D (2019)
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis
Eur J Clin Invest, e13088 (in press)
DOI 10.1111/eci.13088, PubMed 30762236

 
Page visits: 113694